Nanomedicine, through a platform of technical solutions, addresses complex medical challenges, such as messenger (m)RNA vaccines. These vaccines, realized during the global pandemic that accelerated research and innovation, owe their success to nanotechnology, wherein lipid nanoparticles protect the mRNA and deliver it to cells. Nanotechnological approaches were developed to expedite the end of the pandemic, demonstrating potential applications in areas beyond conventional treatments like chemotherapy, surgery, and radiotherapy. Advanced techniques targeting tumors include thermal energy-based methods such as magnetic hyperthermia and photothermal therapy, dynamic therapies like photodynamic therapy, gene therapy, immunotherapy, and real-time monitoring of therapeutic effectiveness using theranostic nanoparticles in magnetic resonance imaging (MRI).
The application of nanotechnology has sparked renewed interest in treating infectious diseases such as malaria, tuberculosis, and HIV. Encapsulation therapies using liposomes, polymeric nanoparticles, and nanocrystals can be administered locally or systemically for prolonged or immediate release. The same mRNA-nanotechnology combination is employed as a personalized mRNA vaccine to treat metastatic melanoma, achieving success in recent clinical trials, with promising results in other malignancies as well.
Nanomedicine encompasses a wide range of innovations, including advanced targeted drug delivery systems, groundbreaking gene therapies using nanoparticles, cutting-edge biosensors, state-of-the-art diagnostics, personalized nanomedicine, and applications in neurological disorders.
Biosensors, precisely calibrated to detect molecular abnormalities well before symptoms manifest, herald a revolution in patient care. Designed with remarkable accuracy, nanoparticles will navigate the human body, identifying abnormalities from their onset, reshaping the entire paradigm of preventive healthcare.
The achievements of nanotechnology seamlessly extend into therapeutic methodologies, marking a shift from conventional approaches to highly targeted treatments. Molecular precision and nanocarriers promise the delivery of therapeutic payloads exclusively to affected cells, minimizing side effects, enhancing treatment efficacy, and significantly improving quality of life.
Public awareness and education about the benefits and potential risks of nanotechnology in healthcare are imperative. These efforts will support responsible decision-making, ethical practices, and the establishment of a social framework for the positive integration of nanotechnological advancements into the medical community.
In the future, nanotechnology will lead innovation in medicine, laying the foundation for preventive measures, ensuring ethical practices based on global collaboration, and fostering public awareness.
Konstantinos Kouskoukis
Professor of Dermatology – Lawyer
B’ Vice President GDHI
President Hellenic Academy of Thermal Medicine
President World Academy of Chinese & Complimentary Medicine